OCUL icon

Ocular Therapeutix
OCUL

Overview Fund Activity

71 hedge funds and large institutions have $380M invested in Ocular Therapeutix in 2015 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 38 increasing their positions, 6 reducing their positions, and 10 closing their positions.

Holders
71
Holders Change
+14
Holders Change %
+24.56%
% of All Funds
1.91%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
24
Increased
38
Reduced
6
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$57.8M
2
Capital World Investors
2
Capital World Investors
California
$42.6M
3
Federated Hermes
3
Federated Hermes
Pennsylvania
$28.6M
4
Capital Research Global Investors
4
Capital Research Global Investors
California
$59.8M
5
Jennison Associates
5
Jennison Associates
New York
$16.1M

Top Sellers

1
RIM
1
RS Investment Management
California
$0
2
PVMCV
2
Polaris Venture Management Co V
Massachusetts
$25.9M
3
SHI
3
SV Health Investors
Massachusetts
$40.6M
4
BP
4
Ballentine Partners
Massachusetts
$0
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$18.7M
Name Holding Trade Value Shares
Change 		Shares
Change %
SIM
76
Spark Investment Management
New York
– -$3.67M -87,500 Closed
Principal Financial Group
77
Principal Financial Group
Iowa
– -$2.27M -54,000 Closed
Allianz Asset Management
78
Allianz Asset Management
Germany
– -$2.23M -53,045 Closed
CCM
79
Cadian Capital Management
New York
– -$1.47M -35,000 Closed
CIP
80
Convergence Investment Partners
Florida
– -$802K -19,100 Closed
SG Americas Securities
81
SG Americas Securities
New York
– -$104K -2,471 Closed
TRCT
82
Tower Research Capital (TRC)
New York
– -$21K -509 Closed
1 2 3
4